Duplicate Therapy
Customize your policy alerts
Sign up for QualChoice Policy AR.QC.CP.PMN.04 alerts
Get alerted when Policy AR.QC.CP.PMN.04 changes without checking for updates manually.
Monitor payer policy activity
This policy governs pharmacy-level duplicate therapy edits that limit members from receiving multiple medications within the same or similar drug classes and defines prior authorization and documentation requirements for overrides; it applies to QualChoice Commercial membership unless state Medicaid overrides apply as noted.
Approval duration for therapy changes and dose titrations updated from 12 months to 30 days.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.